Sign In
Buy BBH
$205.55
-2.46 (-1.18%)
At Close: Jul 31, 2026
How Are Biotech ETFs Reacting to Q4 Earnings Releases?
03:48pm, Tuesday, 21'st Feb 2023
The latest earnings from some of the big biotech players came in at mixed this reporting season.
5 Least-Hurt Biotech ETFs of the Last Week
02:18pm, Wednesday, 15'th Feb 2023
Rising rate worries have weighed on the biotech sector. However, these biotech ETFs still have lost the least in recent days.
Should You Invest in the VanEck Biotech ETF (BBH)?
07:32am, Monday, 23'rd Jan 2023
Sector ETF report for BBH
Can Health Care Stocks Outperform Again In 2023?
06:09pm, Wednesday, 11'th Jan 2023
How a recession could impact health care stocks in 2023. As Covid continues, what it could mean for the health care sector.
BBH: Portfolio Of Large-Cap Biotechnology Stocks Has Delivered Strong Returns
02:45pm, Friday, 02'nd Dec 2022
The BBH ETF has an asset base of $520 million, posted strong growth over the past 6 months, and is trading much higher than its pre-pandemic period price range. BMRN, ARGX, ALNY, BIIB, BGNE, GILD, MRN
Biotech Finally Getting Its Groove Back
11:43am, Friday, 25'th Nov 2022
There's still plenty of room to run to return to prior highs, but some biotech stocks and exchange traded funds are showing signs of life. That's encouraging after what has been a surprisingly long do
Should You Invest in the VanEck Biotech ETF (BBH)?
07:32am, Tuesday, 22'nd Nov 2022
Sector ETF report for BBH
How Are Biotech ETFs Reacting to Q3 Earnings Releases?
09:02am, Wednesday, 09'th Nov 2022
Biotech earnings have come in upbeat in the third quarter.
Assessing the Strength of Biotech Dividends With BBH
10:08am, Friday, 21'st Oct 2022
Biotechnology usually isn't the first industry investors think of when it comes to dividends, but some of the more mature companies in the space do deliver payouts. Some of those names reside in the V
Should You Invest in the VanEck Biotech ETF (BBH)?
10:20am, Monday, 19'th Sep 2022 Zacks Investment Research
Sector ETF report for BBH
Should You Invest in the VanEck Biotech ETF (BBH)?
07:32am, Monday, 19'th Sep 2022
Sector ETF report for BBH
Cancer-Drug Maker's Solid Position And Successful Drug Record Drive Growth
05:09pm, Thursday, 08'th Sep 2022
Cancer-drug maker Amgen solidified its position in a highly competitive market by acquiring its rival Mirati Therapeutics.
Consolidation Case for Biotech ETF BBH
02:24pm, Wednesday, 07'th Sep 2022
Eight months into 2022, it's fair to say that it's been a tepid year of deal-making in the biotechnology industry, and that's one reason why the related stocks and exchange traded funds are scuffling.
Why Now Could Be The Time To Consider Neuroscience Investments
04:45am, Saturday, 27'th Aug 2022
Recognition that aging populations will give rise to new healthcare needs and heightened awareness of mental health issues are bringing renewed focus to neurological health. Recent advances in genomic
What The Inflation Reduction Act Means For Drug Prices
01:24am, Friday, 26'th Aug 2022
The recently enacted Inflation Reduction Act looks to rein in prescription drug prices and could impact the pharma industry's long-term financial performance. The legislation caps out-of-pocket costs
